v3.21.1
Condensed Statements of Operations (unaudited) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenues
Operating expenses:    
Research and development 6,937,610 6,631,928
General and administrative 6,261,905 5,951,106
Total operating expenses 13,199,515 12,583,034
Operating loss (13,199,515) (12,583,034)
Other income (expense):    
Interest income 41,149 290,313
Interest expense (311,410) (312,200)
Equity modification expense (2,290,688)
Amortization of debt discount and offering costs (504,497) (439,851)
Total other expense (3,065,446) (461,738)
Net loss $ (16,264,961) $ (13,044,772)
Basic and diluted net loss per share (in Dollars per share) $ (0.33) $ (0.30)
Weighted average common shares outstanding - basic and diluted (in Shares) 48,814,353 42,816,616

Source